Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection

Scandinavian Journal of Immunology

Volumn 51, Issue 5, 2000, Pages 533-541

  Bosque, Florence ^a,b,c   Saravia, N G ^b   Valderrama, L ^b   Milon, G ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^c Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA PANAMENSIS; LEISHMANIASIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; ENDEMIC DISEASES; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; LEISHMANIA GUYANENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RECURRENCE; RISK FACTORS; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034101408     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00724.x     Document Type: Article

References (32)

1. 1 Pirmez C, Yamamura M, Uyemura K et al. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993;91: 1390-5.
2. 2 Barral-Netto M, Brodskyn C, Bomfim G et al. Cytokine regulation in human American cutaneous leishmaniasis. In: Tapia FJ, Caceres-Ditmar G, Sanchez MA, eds. Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. RG Landes Company, Austin 1996: 153-72.
3. 3 Melby PC, Andrade-Narvaez FJ, Darnell BJ et al. Increased proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infec Immun 1994;62:837-42.
4. 4 Louzir H, Melby PC, Salah AB et al. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to L. major J Infec Dis 1998;177:1687-95.
5. 5 Weigle KA, Santrich C, Martinez F, Valderrama L, Saravia NG. Epidemiology of leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Inf Dis 1993;168:699-708.
6. 6 Saravia NG, Weigle K, Segura I et al. Recurrent lesions in human Leishmania braziliensis infection: reactivation or reinfection? Lancet 1990;336:398-402.
7. 7 Weigle KA, Valderrama L, Arias AL, Santrich C, Saravia NG. Leishmanin skin test: standardization and evaluation of reaction and sensitization. Am J Trop Med Hyg 1991;44:260-7.
8. 8 Weigle KA, Santrich C, Martinez F, Valderrama L, Saravia NG. Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity. J Inf Dis 1993;168:709-14.
9. 9 Saravia NG, Holguin AF, McMahon-Pratt D, D'Alessandro A. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 1985;34:714-20.
10. 10 Rey JA, Travi BL, Valencia AZ, Saravia NG. Infectivity of the subspecies of the Leishmania braziliensis complex in vivo and in vitro. Am J Trop Med Hyg 1990;43:623-31.
11. 11 Senekjie HA. Studies on the culture of Leishmania tropica. Trans Roy Soc Trop Med Hyg 1939;33:267-9.
12. 12 Bosque F, Milon G, Valderrama L, Saravia NG. Permissiveness of human monocyte-derived macrophages to infection by promastigotes of Leishmania (V) panamensis. J Parasitol 1998;84: 1250-6.
13. 13 Robledo S, Wozencraft A, Valencia AZ, Saravia NG. Human monocyte infection by Leishmania (Viannia) panamensis: role of complement receptors and correlation of susceptibility in vitro with clinical phenotype. J Immunol 1994;147:3575-80.
14. 14 Prentice RL. A generalization of the Probit and Logit methods for dose response curves. Biometrics 1976;32:761-9.
15. 15 Saravia NG, Valderrama L, Labrada M et al. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Inf Dis 1989; 159:725-35.
16. 16 Oppenheim JJ, schecter B. Lymphocyte transformation. In: Rose NR, Friedman H, eds. Manual of Clinical Immunology: Cellular Components of the Immune Response. American Society for Microbiology, Washington 1980: 233-46.
17. 17 Carpenter AB. Enzyme-linked immunoassays. In: Rose NR, Conway de Macario E, Fahey JL, Friedman H, Penn GM, eds. Manual of Clinical Immunology. American Society for Microbiology, Washington 1992: 2-9.
18. 18 Castés M, Moros Z, Martinez A et al. Cell mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Parasite Immunol 1989;11:211-22.
19. 19 Carvalho EM, Johnson WD, Barreto E et al. Cell mediated immunity in American cutaneous leishmaniasis. J Immunol 1985;135: 4144-8.
20. 20 Castés M, Agnelli A, Rondon AJ. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol 1983;27:176-86.
21. 21 Schubach A, Marzochi MCA, Cuzzi-Maya T et al. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 1998;58:824-7.
22. 22 Guevara P, Ramirez JL, Rojas E, Scorza JV, Gonzalez N, Añez N. Leishmania braziliensis in blood 30 years after cure. Lancet 1993;341:1341.
23. 23 Nacy CA, Meltzer MS. T-cell mediated activation of macrophages. Curr Opin Immunol 1992;3:330-5.
24. 24 Convit J, Pinardi ME, Rondon AJ. Diffuse cutaneous leishmaniasis: a disease due to immunological defect of the host. Trans R Soc Trop Med Hyg 1972;66:603-10.
25. 25 Convit J, Ulrich M, Fernandez CL et al. The clinical and immunologic spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:444-8.
26. 26 Bryceson ADM, Chulay JD, Ho M et al. Visceral leishmaniasis unresponsive to antimonial drugs. II. Clinical and immunological studies. Trans R Soc Trop Med Hyg 1985;79:700-4.
27. 27 Walton BC, Valverde LC. Racial differences in espundia. Ann Trop Med Parasitol 1979;73:23-9.
28. + T cells. Infect Immun 1993;61:3730-8.
29. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun 1994;62: 2575-81.
30. + cells. Eur J Immunol 1993;23:1181-4.
31. + T cells during initiation of infection. J Exp Med 1994;179:447-58.
32. 32 Reiner ME, Winnie NG, McMaster WR. Parasite accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex products. J Immunol 1987;138: 1919-25.